Colorectal Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colorectal Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 3 (2006), Issue 6 (June)

1. Correlation of reversion-inducing cysteine-rich protein with kazal motifs (RECK) and extracellular matrix metalloproteinase inducer (EMMPRIN), with MMP-2, MMP-9, and survival in colorectal cancer.
   Cancer Lett, 237(2): 289-97. [Abstract] [Full-text]
2. Start codon polymorphisms in the vitamin D receptor and colorectal cancer risk.
   Cancer Lett, 237(2): 199-206. [Abstract] [Full-text]
3. Sacral osteomyelitis after ileal pouch-anal anastomosis: report of four cases.
   Dis Colon Rectum, 49(6): 913-8. [Abstract] [Full-text]
4. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
   Dis Colon Rectum, 49(6): 883-94. [Abstract] [Full-text]
5. Prediction of postoperative mortality in elderly patients with colorectal cancer.
   Dis Colon Rectum, 49(6): 816-24. [Abstract] [Full-text]
6. Is routine magnetic resonance imaging justified for the early detection of resectable liver metastases from colorectal cancer?
   Dis Colon Rectum, 49(6): 810-5. [Abstract] [Full-text]
7. Abdominoperineal excision with partial anterior en bloc resection in multimodal management of low rectal cancer: a strategy to reduce local recurrence.
   Dis Colon Rectum, 49(6): 833-40. [Abstract] [Full-text]
8. Endoscopic posterior mesorectal resection after transanal local excision of T1 carcinomas of the lower third of the rectum.
   Dis Colon Rectum, 49(6): 919-24. [Abstract] [Full-text]
9. Adenocarcinoma in an ileoanal pouch formed for ulcerative colitis in a patient with primary sclerosing cholangitis and a liver transplant: report of a case and review of the literature.
   Dis Colon Rectum, 49(6): 909-12. [Abstract] [Full-text]
10. Laparoscopic colon resection for polyps: a good novice case?
    Dis Colon Rectum, 49(6): 879-82. [Abstract] [Full-text]
11. POSSUM predicts decreased overall survival in curative resection for colorectal cancer.
    Dis Colon Rectum, 49(6): 825-32. [Abstract] [Full-text]
12. Colorectal cancer after start of nonsteroidal anti-inflammatory drug use.
    Am J Med, 119(6): 494-502. [Abstract] [Full-text]
13. Should adjuvant chemotherapy become standard treatment for patients with stage II colon cancer? For the proposal.
    Lancet Oncol, 7(6): 515-6. [Abstract] [Full-text]
14. Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels.
    Int J Radiat Oncol Biol Phys, 65(3): 907-16. [Abstract] [Full-text]
15. VEGF-associated tyrosine kinase inhibition increases the tumor response to single and fractionated dose radiotherapy.
    Int J Radiat Oncol Biol Phys, 65(3): 836-41. [Abstract] [Full-text]
16. Epidermal growth factor receptor as a prognostic factor in locally advanced rectal-cancer patients treated with preoperative chemoradiation.
    Int J Radiat Oncol Biol Phys, 65(3): 705-12. [Abstract] [Full-text]
17. FDG-PET/CT in the evaluation of anal carcinoma.
    Int J Radiat Oncol Biol Phys, 65(3): 720-5. [Abstract] [Full-text]
18. Prostatic irradiation is not associated with any measurable increase in the risk of subsequent rectal cancer.
    Int J Radiat Oncol Biol Phys, 65(3): 661-8. [Abstract] [Full-text]
19. Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro.
    Biotechnol Bioeng, 94(4): 710-21. [Abstract] [Full-text]
20. Lymph node-based prognostics: limitations with individualized cancer treatment.
    Am J Clin Oncol, 29(3): 298-304. [Abstract] [Full-text]
21. Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer: potential benefits and COX-2 as the common mediator in pain, toxicities and survival?
    Am J Clin Oncol, 29(3): 232-9. [Abstract] [Full-text]
22. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer.
    Am J Clin Oncol, 29(3): 219-24. [Abstract] [Full-text]
23. Anorectal malignant melanoma: morphologic and immunohistochemical features.
    Am J Clin Pathol, 126(1): 93-100. [Abstract] [Full-text]
24. First- and second-line therapy of metastatic colorectal cancer.
    Expert Rev Anticancer Ther, 6(6): 921-30. [Abstract] [Full-text]
25. Phase II study of mitomycin-C, adriamycin, cisplatin (MAP) and Bleomycin-CCNU in patients with advanced cancer of the anal canal: An eastern cooperative oncology group study E7282.
    Invest New Drugs, 24(5): 447-54. [Abstract] [Full-text]
26. Malnutrition was associated with poor quality of life in colorectal cancer: a retrospective analysis.
    J Clin Epidemiol, 59(7): 704-9. [Abstract] [Full-text]
27. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies.
    Gut, 55(7): 1000-6. [Abstract] [Full-text]
28. Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer.
    Gut, 55(7): 1007-11. [Abstract] [Full-text]
29. Gli1, downregulated in colorectal cancers, inhibits proliferation of colon cancer cells involving Wnt signalling activation.
    Gut, 55(7): 991-9. [Abstract] [Full-text]
30. Overexpression of RB1 transcript is significantly correlated with 13q14 allelic imbalance in colorectal carcinomas.
    Int J Cancer, 119(5): 1061-6. [Abstract] [Full-text]
31. In vivo luminescent imaging of cyclosporin A-mediated cancer progression in rats.
    Transplantation, 81(11): 1558-67. [Abstract] [Full-text]
32. Physical activity and the risk of colon cancer among women: a prospective cohort study (United States).
    Int J Cancer, 119(2): 385-91. [Abstract] [Full-text]
33. Polymorphisms in the genes involved in the arachidonic acid-pathway, fish consumption and the risk of colorectal cancer.
    Int J Cancer, 119(2): 297-303. [Abstract] [Full-text]
34. Diet, lifestyle and risk of K-ras mutation-positive and -negative colorectal adenomas.
    Int J Cancer, 119(2): 398-405. [Abstract] [Full-text]
35. Familial risk of colon and rectal cancer in Iceland: evidence for different etiologic factors?
    Int J Cancer, 119(2): 304-8. [Abstract] [Full-text]
36. Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response.
    Int J Cancer, 119(2): 406-13. [Abstract] [Full-text]
37. The postoperative surveillance of patients with colon cancer and rectal cancer.
    Am J Surg, 192(1): 100-8. [Abstract] [Full-text]
38. Efficacy of 3-dimensional endorectal ultrasonography compared with conventional ultrasonography and computed tomography in preoperative rectal cancer staging.
    Am J Surg, 192(1): 89-97. [Abstract] [Full-text]
39. Targeted molecular therapy of the PI3K pathway: therapeutic significance of PI3K subunit targeting in colorectal carcinoma.
    Ann Surg, 243(6): 833-42; discussion 843-4. [Abstract] [Full-text]
40. Detection of aberrations of ubiquitin-conjugating enzyme E2C gene (UBE2C) in advanced colon cancer with liver metastases by DNA microarray and two-color FISH.
    Cancer Genet Cytogenet, 168(1): 30-5. [Abstract] [Full-text]
41. Proteomic analysis of colorectal cancer reveals alterations in metabolic pathways: mechanism of tumorigenesis.
    Mol Cell Proteomics, 5(6): 1119-30. [Abstract] [Full-text]
42. Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review.
    Clin Infect Dis, 43(2): 223-33. [Abstract] [Full-text]
43. Modulatory effects of quercetin on proliferation and differentiation of the human colorectal cell line Caco-2.
    Cancer Lett, 238(2): 248-59. [Abstract] [Full-text]
44. Altered iron metabolism, transferrin receptor 1 and ferritin in patients with colon cancer.
    Cancer Lett, 238(2): 188-96. [Abstract] [Full-text]
45. Risk factors for tumour present in a circumferential line of resection after excision of rectal cancer.
    Br J Surg, 93(7): 860-5. [Abstract] [Full-text]
46. Management of intrahepatic recurrence after curative treatment of colorectal liver metastases.
    Br J Surg, 93(7): 854-9. [Abstract] [Full-text]
47. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary.
    Br J Surg, 93(7): 872-8. [Abstract] [Full-text]
48. Population-based study of prognostic factors in stage II colonic cancer.
    Br J Surg, 93(7): 866-71. [Abstract] [Full-text]
49. Biology of colorectal liver metastases: A review.
    J Surg Oncol, 94(1): 68-80. [Abstract] [Full-text]
50. Prognostic impact of orotate phosphoribosyl transferase activity in resectable colorectal cancers treated by 5-fluorouracil-based adjuvant chemotherapy.
    J Surg Oncol, 94(1): 45-50. [Abstract] [Full-text]
51. Prognostic significance of CEA levels and detection of CEA mRNA in draining venous blood in patients with colorectal cancer.
    J Surg Oncol, 94(1): 3-8. [Abstract] [Full-text]
52. Expression of the p73 protein in rectal cancers with or without preoperative radiotherapy.
    Int J Radiat Oncol Biol Phys, 65(4): 1143-8. [Abstract] [Full-text]
53. Definition and delineation of the clinical target volume for rectal cancer.
    Int J Radiat Oncol Biol Phys, 65(4): 1129-42. [Abstract] [Full-text]
54. Androgen receptor expression in normal, hyperplastic and neoplastic hepatoid glands in the dog.
    Res Vet Sci, 81(2): 231-6. [Abstract] [Full-text]
55. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer.
    N Engl J Med, 354(26): 2751-63. [Abstract] [Full-text]
56. The role of UGT1A1*28 polymorphism in the pharmacodynamics and pharmacokinetics of irinotecan in patients with metastatic colorectal cancer.
    J Clin Oncol, 24(19): 3061-8. [Abstract] [Full-text]

© 2004-2008 Colorectal Cancer Research Today. All Rights Reserved.